Literature DB >> 27321178

Activation of CK1ɛ by PP2A/PR61ɛ is required for the initiation of Wnt signaling.

M Vinyoles1,2, B Del Valle-Pérez1, J Curto1, M Padilla1, A Villarroel1, J Yang3, A G de Herreros2,4, M Duñach1.   

Abstract

Canonical Wnt signaling induces the stabilization of β-catenin, its translocation to the nucleus and the activation of target promoters. This pathway is initiated by the binding of Wnt ligands to the Frizzled receptor, the association of the LRP5/6 co-receptor and the formation of a complex comprising Dvl-2, Axin and protein kinases CK1α, ɛ, γ and GSK3. Among these, activation of CK1ɛ, constitutively bound to LRP5/6 through p120-catenin, is required for the association of the rest of the components. We describe here that CK1ɛ is activated by the PP2A/PR61ɛ phosphatase. Binding of Wnt ligands promotes the interaction of LRP5/6-associated CK1ɛ with Frizzled-bound PR61ɛ regulatory subunit, facilitating the access of PP2A catalytic subunit to CK1ɛ and its activation, what enables the recruitment of Dvl-2 to the receptor complex and the initiation of the Wnt pathway. Our results uncover the mechanism of activation of the canonical Wnt pathway by its ligands.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27321178      PMCID: PMC5173447          DOI: 10.1038/onc.2016.209

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  45 in total

1.  Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex.

Authors:  Vivian S W Li; Ser Sue Ng; Paul J Boersema; Teck Y Low; Wouter R Karthaus; Jan P Gerlach; Shabaz Mohammed; Albert J R Heck; Madelon M Maurice; Tokameh Mahmoudi; Hans Clevers
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

Review 2.  Dishevelled: The hub of Wnt signaling.

Authors:  Chan Gao; Ye-Guang Chen
Journal:  Cell Signal       Date:  2009-12-13       Impact factor: 4.315

3.  Upon Wnt stimulation, Rac1 activation requires Rac1 and Vav2 binding to p120-catenin.

Authors:  Gabriela Valls; Montserrat Codina; Rachel K Miller; Beatriz Del Valle-Pérez; Meritxell Vinyoles; Carme Caelles; Pierre D McCrea; Antonio García de Herreros; Mireia Duñach
Journal:  J Cell Sci       Date:  2012-09-03       Impact factor: 5.285

4.  Specific phosphorylation of p120-catenin regulatory domain differently modulates its binding to RhoA.

Authors:  Julio Castaño; Guiomar Solanas; David Casagolda; Imma Raurell; Patricia Villagrasa; Xosé R Bustelo; Antonio García de Herreros; Mireia Duñach
Journal:  Mol Cell Biol       Date:  2006-12-28       Impact factor: 4.272

5.  p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction.

Authors:  Jose Piedra; Susana Miravet; Julio Castaño; Héctor G Pálmer; Nora Heisterkamp; Antonio García de Herreros; Mireia Duñach
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

6.  N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.

Authors:  Eric Haÿ; Emmanuel Laplantine; Valérie Geoffroy; Monique Frain; Thomas Kohler; Ralph Müller; Pierre J Marie
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

7.  Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling.

Authors:  Cristina-Maria Cruciat; Bisei Ohkawara; Sergio P Acebron; Emil Karaulanov; Carmen Reinhard; Dierk Ingelfinger; Michael Boutros; Christof Niehrs
Journal:  Science       Date:  2010-01-22       Impact factor: 47.728

8.  Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain.

Authors:  W Hsu; L Zeng; F Costantini
Journal:  J Biol Chem       Date:  1999-02-05       Impact factor: 5.157

9.  Wnt3a-mediated formation of phosphatidylinositol 4,5-bisphosphate regulates LRP6 phosphorylation.

Authors:  Weijun Pan; Sun-Cheol Choi; He Wang; Yuanbo Qin; Laura Volpicelli-Daley; Laura Swan; Louise Lucast; Cynthia Khoo; Xiaowu Zhang; Lin Li; Charles S Abrams; Sergei Y Sokol; Dianqing Wu
Journal:  Science       Date:  2008-09-05       Impact factor: 47.728

10.  PP2A:B56epsilon is required for Wnt/beta-catenin signaling during embryonic development.

Authors:  Jing Yang; Jinling Wu; Change Tan; Peter S Klein
Journal:  Development       Date:  2003-10-01       Impact factor: 6.868

View more
  7 in total

Review 1.  Spatiotemporal regulation of the Dma1-mediated mitotic checkpoint coordinates mitosis with cytokinesis.

Authors:  Sierra N Cullati; Kathleen L Gould
Journal:  Curr Genet       Date:  2019-01-02       Impact factor: 3.886

2.  A CK1 FRET biosensor reveals that DDX3X is an essential activator of CK1ε.

Authors:  Christine Dolde; Joachim Bischof; Simon Grüter; Anna Montada; Jakob Halekotte; Christian Peifer; Hubert Kalbacher; Ulrich Baumann; Uwe Knippschild; Beat Suter
Journal:  J Cell Sci       Date:  2018-01-04       Impact factor: 5.285

3.  CK1ε and p120-catenin control Ror2 function in noncanonical Wnt signaling.

Authors:  Josué Curto; Beatriz Del Valle-Pérez; Aida Villarroel; Guillem Fuertes; Meritxell Vinyoles; Raúl Peña; Antonio García de Herreros; Mireia Duñach
Journal:  Mol Oncol       Date:  2018-03-14       Impact factor: 6.603

Review 4.  Intracellular Signals Activated by Canonical Wnt Ligands Independent of GSK3 Inhibition and β-Catenin Stabilization.

Authors:  Antonio García de Herreros; Mireia Duñach
Journal:  Cells       Date:  2019-09-25       Impact factor: 6.600

Review 5.  Targeting Casein Kinase 1 (CK1) in Hematological Cancers.

Authors:  Pavlína Janovská; Emmanuel Normant; Hari Miskin; Vítězslav Bryja
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

Review 6.  Protein phosphatase 2A - structure, function and role in neurodevelopmental disorders.

Authors:  Priyanka Sandal; Chian Ju Jong; Ronald A Merrill; Jianing Song; Stefan Strack
Journal:  J Cell Sci       Date:  2021-07-06       Impact factor: 5.235

7.  Repositioning of Etravirine as a Potential CK1ε Inhibitor by Virtual Screening.

Authors:  Luis Córdova-Bahena; Axel A Sánchez-Álvarez; Angel J Ruiz-Moreno; Marco A Velasco-Velázquez
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.